EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An integrated enzymatic and computational pipeline for quantifying off-target base-editing

Alexander G. McFarland, Soon-Keat Ooi, Davin Tafuri, Elahe Kamali, Natalie Cooper, Emma J. Cook, Shantan Reddy, Kelsey Stanton, Chong Xu, Danuta Jarocha, Nils Wellhausen, Beatriz M. Carreno und 5 weitere

Molecular Therapy Advances · 2026-11 · 201894

DOI: 10.1016/j.omta.2026.201894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-11. Verfasst von Alexander G. McFarland und 16 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA base editing is increasingly used for human genetic modification, but methods for monitoring off-target editing are nascent. Here we present a simple model-independent workflow for identifying sites of off-target base-editing in relevant cell types on a genome-wide level. We report that sites of off-target editing by the ABE8e editor could be identified using an ABE8e derivative with restored DSB cleavage activity. This allows marking of enzyme-generated double-stranded (ds) DNA breaks by incorporation of dsDNA oligonucleotides that are transfected into primary target cells. DNA sequencing at sites of oligonucleotide incorporation reported both the genomic location of off-target cleavage and the extent of base-editing nearby. We present a platform combining this cellular (BEiGUIDE-Seq) and computational workflow (CRISPRito) to generate optimized amplicon panels for convenient monitoring of off-target base editing. This work introduces a generalizable strategy to evaluate off-target edits in patient-derived cells, addressing a critical safety gap for clinical base editing.

Förderung

  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

McFarland, A. G., Ooi, S., Tafuri, D., Kamali, E., Cooper, N., Cook, E. J., Reddy, S., Stanton, K., Xu, C., Jarocha, D., Wellhausen, N., Carreno, B. M., Gill, S. I., Roche, A. M., Fraietta, J. A., Bushman, F. D., & Herbst, F. (2026). An integrated enzymatic and computational pipeline for quantifying off-target base-editing. Molecular Therapy Advances, 201894. https://doi.org/10.1016/j.omta.2026.201894

Vancouver

McFarland AG, Ooi S, Tafuri D, Kamali E, Cooper N, Cook EJ, et al. An integrated enzymatic and computational pipeline for quantifying off-target base-editing. Molecular Therapy Advances. 2026:201894. doi:10.1016/j.omta.2026.201894

BibTeX
@article{McFarland2026,
  author = {McFarland, Alexander G. and Ooi, Soon-Keat and Tafuri, Davin and Kamali, Elahe and Cooper, Natalie and Cook, Emma J. and Reddy, Shantan and Stanton, Kelsey and Xu, Chong and Jarocha, Danuta and Wellhausen, Nils and Carreno, Beatriz M. and Gill, Saar I. and Roche, Aoife M. and Fraietta, Joseph A. and Bushman, Frederic D. and Herbst, Friederike},
  title = {An integrated enzymatic and computational pipeline for quantifying off-target base-editing},
  journal = {Molecular Therapy Advances},
  year = {2026},
  pages = {201894},
  doi = {10.1016/j.omta.2026.201894}
}
Kostenlos starten →